https://www.selleckchem.com/pr....oducts/jr-ab2-011.ht
Although most refer AYAs with SCD for birth control (83%), 39% endorsed a preferred method, with 33% of these favoring levonorgestrel intrauterine devices in this population and 40% injectable contraception. Approximately half of respondents (57%) reported that the use of combined hormonal contraceptives was unacceptable despite published guidelines that support potential benefits outweighing theoretical risk in AYAs with SCD. The range of SRH conversations and contraceptive recommendations for AYAs from pediatric SCD providers is br